31
Views
0
CrossRef citations to date
0
Altmetric
Neuromodulation and Interventional

Menstrual Cramps in Anovulatory versus Normally Ovulatory Cycles — SARS-COV-2 Pandemic Daily Data Plus a Meta-Analysis of Cramps and Anovulation

, , , ORCID Icon, , & ORCID Icon show all
Pages 2363-2374 | Received 01 Jan 2024, Accepted 09 Jun 2024, Published online: 09 Jul 2024

References

  • Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21(6):762–778. doi:10.1093/humupd/dmv039
  • Hofmeyr GJ, Bassin J. Dysmenorrhoea. Topic Obstetr Gynaecol. 1996;1996:269–274.
  • Harel Z. Dysmenorrhea in adolescents. In: Annals of the New York Academy of Sciences. Vol. 1135. 2008. doi:10.1196/annals.1429.007
  • Parker MA, Kent AL, Sneddon A, Wang J, Shadbolt B. The menstrual disorder of teenagers (MDOT) study no. 2: period impact and pain assessment (PIPPA) tool validation in a large population-based cross-sectional study of Australian teenagers. J Pediatr Adolesc Gynecol. 2022;35(1):30–38. doi:10.1016/j.jpag.2021.06.003
  • Campbell MA, McGrath PJ. Use of medication by adolescents for the management of menstrual discomfort. Arch Pediatr Adolesc Med. 1997;151(9):905. doi:10.1001/archpedi.1997.02170460043007
  • Andersch B, Milsom I. An epidemiological study of young women with dysmenorrhea. Am J Obstet Gynecol. 1982;144(6):655–660. doi:10.1016/0002-9378(82)90433-1
  • Dawood MY. Dysmenorrhoea and Prostaglandins: pharmacological and Therapeutic Considerations. Drugs. 1981;22(1):42–56. doi:10.2165/00003495-198122010-00003
  • Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294(5548):1871–1875. doi:10.1126/science.294.5548.1871
  • Dawood MY. Dysmenorrhea. Clin Obstet Gynecol. 1990;33(1):168–178. doi:10.1097/00003081-199003000-00023
  • Eldering JA, Nay MG, Hoberg LM, Longcope C, McCracken JA. Hormonal regulation of prostaglandin production by rhesus monkey endometrium. J Clin Endocrinol Metab. 1990;71(3):596–604. doi:10.1210/jcem-71-3-596
  • Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstetrics Gynecol. 2006;108(2):428–441. doi:10.1097/01.AOG.0000230214.26638.0c
  • Wilson L, Kurzrok R. Studies on the motility of the human uterus in vivo. Endocrinology. 1938;23(1):79–86. doi:10.1210/endo-23-1-79
  • Pickles VR. PROSTAGLANDINS AND DYSMENORRHEA: historical Survey. Acta Obstet Gynecol Scand. 1979;58(87 S):7–12. doi:10.3109/00016347909157782
  • Espín López L, Carrillo Verdejo E, González Javier F, Ordoñana Martín JR, Gómez-Amor J. Incidence of anovulatory menstrual cycles among dysmenorrheic and non-non-dysmenorrheic [corrected] women: effects on symptomatology and mood. Psicothema. 2010;22(4):654–658.
  • Seidman LC, Brennan KM, Rapkin AJ, Payne LA. Rates of anovulation in adolescents and young adults with moderate to severe primary dysmenorrhea and those without primary dysmenorrhea. J Pediatr Adolesc Gynecol. 2018;31(2):94–101. doi:10.1016/j.jpag.2017.09.014
  • Akman AO, Bozdag G, Pehlivantürk-Kizilkan M, Akgul S, Derman O, Kanbur N. Menstrual cycle pain is independent of ovulation in adolescents with primary dysmenorrhea. J Pediatr Adolesc Gynecol. 2021;34(5):635–642. doi:10.1016/j.jpag.2021.04.001
  • Bann S, Goshtasebi A, Shirin S, Prior JC. A one-year observational cohort study of menstrual cramps and ovulation in healthy, normally ovulating women. Sci Rep. 2022;12(1). doi:10.1038/s41598-022-08658-3
  • Prior JC, Vigna YM, Schechter MT, Burgess AE. Spinal bone loss and ovulatory disturbances. N Engl J Med. 1990;323(18):1221–1227. doi:10.1056/nejm199011013231801
  • Prior JC. Exercise associated menstrual disturbances. Reprod Endocrinol Surg Technol. 1996;1996:1077–1091.
  • Prior JC, Vigna YM, Schulzer M, Hall JE, Bonen A. Determination of luteal phase length by quantitative basal temperature methods: validation against mid-cycle LH peak. Clin Invest Med. 1990;13(3):123–131.
  • Bedford JL, Prior JC, Hitchcock CL, Barr SI. Detecting evidence of luteal activity by least-squares quantitative basal temperature analysis against urinary progesterone metabolites and the effect of wake-time variability. Eur J Obstet Gynecol Reprod Biol. 2009;146(1):76–80. doi:10.1016/j.ejogrb.2009.05.001
  • Garcia de Leon R, Baaske A, Albert AY, et al. Higher perceived stress during the COVID-19 pandemic increased menstrual dysregulation and menopause symptoms. Women’s Health. 2023;19. doi:10.1177/17455057231199051
  • Prior JC. Adaptive, reversible, hypothalamic reproductive suppression: more than functional hypothalamic amenorrhea. Front Endocrinol. 2022;13. doi:10.3389/fendo.2022.893889
  • Shafrir AL, Wise LA, Palmer JR, et al. Validity of self-reported endometriosis: a comparison across four cohorts. Hum Reprod. 2021;36(5):1268–1278. doi:10.1093/humrep/deab012